Please assess the completion status of the following clinical trial:

Trial Title: Prednisone for Heart Failure Patients With Hyperuricemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-70 years old~* NYHA Class III-IV~* EF =\< 40%~* Uric acid =\> 9.5 mg/dL~Exclusion Criteria:~* Acute gouty arthritis~* Any condition (other than CHF) that could limit the use of prednisone or allopurinol~* Any concurrent disease likely to limit life expectancy.~* Active myocarditis, or an obstructive or restrictive cardiomyopathy~* Heart Attack, Stroke, Unstable Angina or Cardiac surgery within previous 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- prednisone (Type: EXPERIMENTAL): None
- allopurinol (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).